ACM
GSK icon

Anfield Capital Management’s GSK GSK Stock Holding History

Anfield Capital Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$102K Buy
1,852
+1,668
+907% +$90.4K 0.03% 175
2025
Q4 		$9.02K Buy
184
+167
+982% +$7.79K ﹤0.01% 346
2025
Q3 		$734 Buy
17
+15
+750% +$586 ﹤0.01% 537
2025
Q2 		$77 Hold
2
– – ﹤0.01% 518
2025
Q1 		$77 Hold
2
– – ﹤0.01% 453
2024
Q4 		$68 Hold
2
– – ﹤0.01% 433
2024
Q3 		$82 Hold
2
– – ﹤0.01% 437
2024
Q2 		$77 Buy
+2
New +$84 ﹤0.01% 385
2021
Q3 		– Sell
-1,100
Closed -$55K – 192
2021
Q2 		$55K Buy
+1,100
New +$52.9K 0.02% 115
2020
Q1 		– Sell
-320
Closed -$18K – 222
2019
Q4 		$18K Buy
+320
New +$17.8K 0.01% 281

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Anfield Capital Management's GSK Position: Q1 2026 in Review

Anfield Capital Management increased its GSK (GSK) stake by 907% in Q1 2026, buying an estimated $90.4K and bringing the position to 1,852 shares worth $102K. The position accounts for 0.03% of the portfolio, ranked #175.

Anfield Capital Management first reported a position in GSK in Q4 2019 and has held it in 10 quarters since. 1,035 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Anfield Capital Management held 1,852 shares of GSK worth $102K as of Q1 2026.
  • Anfield Capital Management bought 1,668 GSK shares in Q1 2026, an estimated $90.4K.
  • GSK made up 0.03% of Anfield Capital Management's portfolio in Q1 2026, its #175 holding.
  • Anfield Capital Management first reported a position in GSK in Q4 2019 and has held it in 10 quarters since.
  • 1,035 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Anfield Capital Management's 13F filing for Q1 2026, filed 12 May 2026.